![Daniel Ryweck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Ryweck
Directeur Financier/CFO chez
SILO PHARMA, INC.
Fortune : 143 $ au 31/05/2026
Profil
Mr. Daniel E.
Ryweck is a Chief Financial Officer at Silo Pharma, Inc. Mr. Ryweck was previously employed as a Chief Financial Officer by Sun BioPharma, Inc. and a Controller by SUI Group Holdings Ltd. He also served on the board at Dala Petroleum Corp.
and KonaTel, Inc. He received his undergraduate degree from The Curtis L.
Carlson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/08/2025 | 333 ( 0 % ) | 143 $ | 31/05/2026 |
Postes actifs de Daniel Ryweck
| Sociétés | Poste | Début |
|---|---|---|
| SILO PHARMA, INC. | Directeur Financier/CFO | 27/09/2022 |
Anciens postes connus de Daniel Ryweck
| Sociétés | Poste | Fin |
|---|---|---|
Dala Petroleum Corp.
 Dala Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Directeur/Membre du Conseil | 31/08/2017 |
| KONATEL, INC. | Directeur/Membre du Conseil | 31/08/2017 |
| SUN BIOPHARMA INC | Directeur Financier/CFO | 01/09/2015 |
| SUI GROUP HOLDINGS LIMITED | Compliance Officer | 31/12/2019 |
Formation de Daniel Ryweck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Mill City Ventures III Ltd.
 Mill City Ventures III Ltd. Finance/Rental/LeasingFinance Provides short-term finance solutions to private businesses, micro and small-cap public companies and high-net-worth individuals | Finance |
Silo Pharma, Inc.
 Silo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a developmental stage biopharmaceutical company that focuses on merging traditional therapeutics with psychedelic research | Health Technology |
The Curtis L. Carlson School of Management
 The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dala Petroleum Corp.
Dala Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Energy Minerals |
Panbela Therapeutics, Inc.
 Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
KonaTel, Inc.
 KonaTel, Inc. Wireless TelecommunicationsCommunications Provides hosted communication platform as a service and mobile solutions | Communications |
